Chemed Corp logo

Chemed Corp(CHE)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
2-STAR RATING
PASS
LAST CLOSE
$508.29
10/19/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CHE

10/19/2026: CHE (2-star) is currently NOT-A-BUY. Pass it for now.

Chemed Corporation is a diversified holding company that operates two primary businesses: VITAS Healthcare, a leader in hospice care, and Roto-Rooter, a dominant brand in plumbing and water restoration. The company is known for its strong cash-generative business model and consistent dividend history, making it a defensive play for long-term investors. Its main growth story centers on the increasing demand for hospice services due to aging demographics and the essential nature of its plumbing services. Primary risks include heavy dependence on government healthcare reimbursements and competition for skilled labor. The stock may suit investors seeking long-term stability rather than rapid growth, with monitoring focused on healthcare regulatory policy.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitChemed offers steady, predictable growth rather than explosive, high-multiple growth.
Momentum investorStrong fit while signal remains positiveThe stock often trends upward with consistent operational performance, appealing to momentum-based strategies.
Value investorMixed fitThe valuation can appear premium given the quality and stability of the business, requiring careful entry points.
Dividend investorStrong fitReliable cash flows support a sustainable and growing dividend payout.
Low-risk investorStrong fitThe essential nature of both hospice and plumbing services provides defensive characteristics during market volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock can experience moderate fluctuations based on healthcare policy updates or general market sentiment.
Valuation riskMediumShares often trade at a premium due to high business quality, creating valuation sensitivity.
Competition risk (Hospice and Home Services)MediumFragmented markets in both hospice and plumbing ensure persistent local and national competitive pressure.
Business qualityStrongThe company operates dominant, essential service franchises with strong cash conversion.
Dividend incomeLowWhile consistent, the yield is typically lower than high-yield income investments, focusing more on growth.
Execution riskMediumSuccess relies on maintaining high service standards and navigating complex regulatory healthcare environments.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -0.78%
Avg. Invested days 50
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/19/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CHE receives a 3-star rating, supported by solid unit economics. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
CHE has moderate overall fundamentals (3 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, solid cash generation (FCF margin 12.9%) and solid profitability (net margin 10.5%) are partially offset by negative earnings growth (-12.2%), moderate revenue growth (+4.1%), modest insider ownership of 1.94%.

Financial Health Rating

★★★★★
CHE's financial health is supported by solid cash strength, including free-cash-flow generation (12.9% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is CHE's strongest growth driver at +4.1% FY2025 versus FY2024 (moderate, 3 stars). By comparison, while earnings growth (-12.2%, negative) and free-cash-flow growth (-11.5%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 106.2% and approximately 90.7% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 1.94% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 11.36%
AQR Capital Management LLC 7.44%
Vanguard Portfolio Management, LLC 6.02%
Vanguard Capital Management, LLC 4.62%
Acadian Asset Management LLC 3.47%

Unit Economics (Per $1K Revenue)

★★★★★
CHE generates approximately $300 of gross profit, $134 of operating income, and $129 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins, cash conversion, and capital efficiency support the rating.

Economic Dimensions

★★★★★
Effective Tax Rate: 25.45%

Quantitative Style Profile

★★★★★
CHE has a high-quality, liquid, relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Quality TiltLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 6.70B USD
Price to earnings Ratio 25.77
1Y Target Price 571.6
Price to earnings Ratio 25.77
1Y Target Price 571.6
Volume (30-day avg) 147.9K shares
Beta 0.51
52 Weeks Range 364.23 - 556.27
Updated Date 10/18/2026
52 Weeks Range 364.23 - 556.27
Updated Date 10/18/2026
Dividends yield (FY) 0.47%
Basic EPS (TTM) 19.88

How Company Makes Money

Business areaWhat it includesRetail investor read
VITAS HealthcareEnd-of-life, palliative, and hospice care services reimbursed primarily by Medicare.This is a stable, aging-demographic-driven revenue stream.
Roto-RooterResidential and commercial plumbing, drain cleaning, and water restoration services.This is an essential service business with strong pricing power and recurring customer demand.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Advertisement

Earnings Date

Report Date 2026-10-27
When After Market
Estimate 5.93
Actual -

Profitability

Profit Margin 10.6%
Operating Margin (TTM) 13.25%

Management Effectiveness

Return on Assets (TTM) 13.45%
Return on Equity (TTM) 27.11%

Valuation

Trailing PE 25.77
Forward PE 18.18
Enterprise Value 6.76B
Price to Sales(TTM) 2.58
Enterprise Value 6.76B
Price to Sales(TTM) 2.58
Enterprise Value to Revenue 2.61
Enterprise Value to EBITDA 15.41
Shares Outstanding 13.07M
Shares Floating 11.85M
Shares Outstanding 13.07M
Shares Floating 11.85M
Percent Insiders 1.94
Percent Institutions 106.17

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.